Success Metrics

Active Trials
1(33%)

Phase Distribution

Ph phase_2
1
33%
Ph not_applicable
2
67%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(2)
Other(1)

Detailed Status

unknown1
Recruiting1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
N/A
Most Advanced
Phase 2

Trials by Phase

Phase 21 (33.3%)
N/A2 (66.7%)

Trials by Status

unknown133%
recruiting133%
enrolling_by_invitation133%

Recent Activity

1 active trials
Showing 3 of 3
recruitingnot_applicable

Motor Network Physiology

NCT04957095
enrolling_by_invitationnot_applicable

The Antiemetic Effects of Increased Splanchnic Perfusion, Induced by the Gut Hormone GIP, in Healthy Individuals

NCT07687589
unknownphase_2

Apomorphine Effects on Pain in Parkinson's Disease

NCT04879134

Clinical Trials (3)

Showing 3 of 3 trials
NCT04957095Not Applicable

Motor Network Physiology

Recruiting
NCT07687589Not Applicable

The Antiemetic Effects of Increased Splanchnic Perfusion, Induced by the Gut Hormone GIP, in Healthy Individuals

Enrolling By Invitation
NCT04879134Phase 2

Apomorphine Effects on Pain in Parkinson's Disease

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3